Search research articles
Contact Us
Filters
Showing results (71-80 of 174) with videos related to
Page
of 18
Sort By:
Obesity (Silver Spring, Md.)
|
June 12, 2017
Circulating Adiponectin Levels Differ Between Patients with Multiple Myeloma and its Precursor Disease
Jonathan N Hofmann, Sham Mailankody, Neha Korde, et al.
Kidney Medicine
|
August 5, 2024
Chimeric Antigen Receptor (CAR) T-Cell Therapy Use in Patients with Multiple Myeloma and Kidney Failure on Maintenance Hemodialysis: A Report of 2 Cases
Wai Lun Will Pak, Natalie A Brumwell, Charlene C Kabel, et al.
Scientific Reports
|
October 18, 2019
Cereblon gene variants and clinical outcome in multiple myeloma patients treated with lenalidomide
Phoebe A Huang, Shaunna L Beedie, Cindy H Chau, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
February 6, 2016
Impact of Genes Highly Correlated with MMSET Myeloma on the Survival of Non-MMSET Myeloma Patients
S Peter Wu, Ruth M Pfeiffer, Inhye E Ahn, et al.
JAMA Oncology
|
October 27, 2022
Clinical Trial Participation Among Older Adult Medicare Fee-for-Service Beneficiaries With Cancer
Angela K Green, Sara M Tabatabai, Carol Aghajanian, et al.
Leukemia & Lymphoma
|
May 9, 2022
Dupilumab for the treatment of refractory lenalidomide rash in patients with multiple myeloma
Alyce M Kuo, Hani Hassoun, Urvi Shah, et al.
Blood Cancer Journal
|
February 6, 2019
Molecular underpinnings of clinical disparity patterns in African American vs. Caucasian American multiple myeloma patients
Dickran Kazandjian, Elizabeth Hill, Malin Hultcrantz, et al.
Medrxiv : the Preprint Server for Health Sciences
|
August 21, 2020
The Effect of Neutropenia and Filgrastim (G-CSF) in Cancer Patients With COVID-19 Infection
Sejal Morjaria, Allen Zhang, Anna Kaltsas Md, et al.
Leukemia & Lymphoma
|
July 15, 2022
Ixazomib and dexamethasone in high risk smoldering multiple myeloma: a clinical and correlative pilot study
Sham Mailankody, Meghan Salcedo, Elizabet Tavitian, et al.
Bone Marrow Transplantation
|
May 6, 2018
Combination therapy with carfilzomib, lenalidomide and dexamethasone (KRd) results in an unprecedented purity of the stem cell graft in newly diagnosed patients with myeloma
Nishant Tageja, Neha Korde, Dickran Kazandjian, et al.
Page
of 18
Search research articles
Search
Showing results (71-80 of 174) with videos related to
Sort By:
Page
of 18
Obesity (Silver Spring, Md.)
|
June 12, 2017
Circulating Adiponectin Levels Differ Between Patients with Multiple Myeloma and its Precursor Disease
Jonathan N Hofmann, Sham Mailankody, Neha Korde, et al.
Kidney Medicine
|
August 5, 2024
Chimeric Antigen Receptor (CAR) T-Cell Therapy Use in Patients with Multiple Myeloma and Kidney Failure on Maintenance Hemodialysis: A Report of 2 Cases
Wai Lun Will Pak, Natalie A Brumwell, Charlene C Kabel, et al.
Scientific Reports
|
October 18, 2019
Cereblon gene variants and clinical outcome in multiple myeloma patients treated with lenalidomide
Phoebe A Huang, Shaunna L Beedie, Cindy H Chau, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
February 6, 2016
Impact of Genes Highly Correlated with MMSET Myeloma on the Survival of Non-MMSET Myeloma Patients
S Peter Wu, Ruth M Pfeiffer, Inhye E Ahn, et al.
JAMA Oncology
|
October 27, 2022
Clinical Trial Participation Among Older Adult Medicare Fee-for-Service Beneficiaries With Cancer
Angela K Green, Sara M Tabatabai, Carol Aghajanian, et al.
Leukemia & Lymphoma
|
May 9, 2022
Dupilumab for the treatment of refractory lenalidomide rash in patients with multiple myeloma
Alyce M Kuo, Hani Hassoun, Urvi Shah, et al.
Blood Cancer Journal
|
February 6, 2019
Molecular underpinnings of clinical disparity patterns in African American vs. Caucasian American multiple myeloma patients
Dickran Kazandjian, Elizabeth Hill, Malin Hultcrantz, et al.
Medrxiv : the Preprint Server for Health Sciences
|
August 21, 2020
The Effect of Neutropenia and Filgrastim (G-CSF) in Cancer Patients With COVID-19 Infection
Sejal Morjaria, Allen Zhang, Anna Kaltsas Md, et al.
Leukemia & Lymphoma
|
July 15, 2022
Ixazomib and dexamethasone in high risk smoldering multiple myeloma: a clinical and correlative pilot study
Sham Mailankody, Meghan Salcedo, Elizabet Tavitian, et al.
Bone Marrow Transplantation
|
May 6, 2018
Combination therapy with carfilzomib, lenalidomide and dexamethasone (KRd) results in an unprecedented purity of the stem cell graft in newly diagnosed patients with myeloma
Nishant Tageja, Neha Korde, Dickran Kazandjian, et al.
Page
of 18